Analysis of total human immunodeficiency virus (HIV)-specific CD4+ and CD8+ T-cell responses: Relationship to viral load in untreated HIV infection

Journal of Virology

Volumn 75, Issue 24, 2001, Pages 11983-11991

  Betts, M R ^a   Ambrozak, D R ^a   Douek, D C ^a   Bonhoeffer, S ^a   Brenchley, J M ^a   Casazza, J P ^a   Koup, R A ^a   Picker, L J ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CD8 ANTIGEN; VIRUS ENVELOPE PROTEIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; FLOW CYTOMETRY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; VIRUS ENVELOPE; VIRUS IMMUNITY; VIRUS LOAD;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FLOW CYTOMETRY; GENE PRODUCTS, ENV; GENE PRODUCTS, GAG; GENE PRODUCTS, NEF; HIV; HIV INFECTIONS; HUMANS; MICE; VIRAL LOAD;

EID: 0035198096     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.24.11983-11991.2001     Document Type: Article

References (46)

1. Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia
2. Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection
3. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine
4. HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function
5. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination
6. + T-cell responses cannot be predicted by major histocompatibility complex class I haplotype
7. Human immunodeficiency virus type 1-specifc cytotoxic T lymphocyte activity is inversely correlated with HIV type 1 viral load in HIV type 1-infected long-term survivors
8. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus
9. Large clonal expansions of CD8+ T cells in acute infectious mononucleosis
10. + T cells in peripheral blood after initiation of highly active antiretroviral therapy
11. Skewed maturation of memory HIV-specific CD8 T lymphocytes
12. Simian immunodeficiency virus evades a dominant epitope-specific cytotoxic T lymphocyte response through a mutation resulting in the accelerated dissociation of viral peptide and MHC class I
13. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection
14. + responses in HIV type 1-infected patients: Comparison with anti-Epstein-Barr virus responses and changes during antiretroviral therapy
15. Maintenance of large numbers of virus-specific CD8+ T cells in HIV-infected progressors and long-term nonprogressors
16. Substantial differences in specificity of HIV-specific cytotoxic T cells in acute and chronic HIV infection
17. Functionally inert HIV-specific cytotoxic T lymphocytes do not play a major role in chronically infected adults and children
18. Late escape from an immunodominant cytotoxic T lymphocytes response associated with progression to AIDS
19. Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques
20. Association between virus-specific cytotoxic T-lymphocyte and helper responses in human immunodeficiency virus type 1 infection
21. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection
22. Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses
23. Kinetics of gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: A longitudinal analysis of rapid progressors and long-term asymptomatics
24. High viral burden in the presence of major HIV-specific CD8(+) T cell expansions: Evidence for impaired CTL effector function
25. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome
26. Effects of in vivo CD8(+) T cell depletion on virus replication in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine
27. HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors
28. Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infection
29. Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection
30. Frequency of HLA allele-specific peptide motifs in HIV-1 proteins correlates with the allele's association with relative rates of disease progression after HIV-1 infection
31. Molecular tracking of an human immunodeficiency virus nef specific cytotoxic T-cell clone shows persistence of clone-specific T-cell receptor DNA but not mRNA following early combination antiretroviral therapy
32. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA
33. Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy
34. Studies in subjects with long-term nonprogressive human immunodeficiency virus infection
35. Decay characteristics of long-lived HIV-1-infected compartments during combination therapy
36. HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression
37. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection
38. High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors
39. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia
40. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes
41. Immunization with a modified vaccinia virus expressing simian immunodeficiency virus (SIV) Gag-Pol primes for an anamnestic Gag-specific cytotoxic T-lymphocyte response and is associated with reduction of viremia after SIV challenge
42. Human immunodeficiency virus type 1 Rev- and Tat-specific cytotoxic T lymphocyte frequencies inversely correlate with rapid progression to AIDS
43. Loss of CD4+ T cell proliferative ability but not loss of human immunodeficiency virus type 1 specificity equates with progression to disease
44. Cytotoxic T-cell abundance and virus load in human immunodeficiency virus type 1 and human T-cell leukaemia virus type 1
45. Viral immune evasion due to persistence of activated T cells without effector function